TNF and rheumatoid arthritis: To date, there are five FDA-approved anti-TNF agents for RA: adalimumab (Humira®), certolizumab pegol (Cimzia®), etanercept (Enbrel®), golimumab (Simponi®), and infliximab (Remicade®) (Agarwal, 2011b).